Asia Pacific Coronary Stents Market Report

Asia Pacific Coronary Stents Market Size

The Asia Pacific coronary stents market size was valued at USD 2.25 billion in 2025 and is anticipated to reach USD 2.43 billion in 2026 from USD 4.50 billion by 2034, growing at a CAGR of 8% during the forecast period from 2026 to 2034.

In the Asia Pacific region, many countries are achieving economic development and undergoing a changeover to a Western Lifestyle and consuming foods with higher fat, and adopting sedentary lifestyles, which are significantly increasing the cases of coronary heart diseases in this region and driving the market growth. Additionally, factors such as the increasing geriatric population and the prevalence of chronic diseases, and the rising adoption of advanced technologies are greatly influencing the market growth.

Moreover, the highest growth rate anticipated by the bioresorbable stent over the above mentioned in the forecast period is due to its high biodegradable properties. In addition, an increase in non-refundable income and growing incidents of heart diseases will boost the market growth in the forecast period.

Technological advancements in coronary stents are directly hiking the prices of these products, which is the primary restraint to the market. Also, the procedures of approval for stent selling and manufacturing are very stringent in the countries of these regions, which are further hampering the growth rate of the Asia Pacific coronary stents market.

Regionally, the Asia Pacific is the fastest-growing regional market across the world. Within the Asia Pacific, the Indian coronary stent market would perform better among all the different nations in this region during the forecast period. In addition, prices of coronary stents rates have been capped by India, which might be a key factor fuelling the market's demand. These factors will help the Indian market to experience the fastest growth in the Coronary Stent market.

The China coronary stent market is expected to account for USD 1.7 billion by 2027 and is the largest market in this region. The segment of Drug-Eluting Stents is expected to grow at a CAGR of 8.6% during the forecast period in this region. Moreover, the segment of Bioresorbable Vascular Scaffolds would grow at the highest CAGR.

REPORT COVERAGE

KEY MARKET PLAYERS

A few of the major market participants operating in the Asia Pacific Coronary Stent Market include

• Medtronic (Ireland)
• Abbott Laboratories (U.S.)
• Boston Scientific Corporation (U.S.)
• Biosensors International Group (Singapore)
• BIOTRONIK (Germany)
• B. Braun Melsungen AG (Germany)
• Terumo Corporation (Japan)
• STENTYS (France)
• MicroPort Scientific Corporation (China)
• Meril Life Sciences (India)
• Vascular Concepts (India)
• Translumina (Germany)

MARKET SEGMENTATION

This Asia Pacific Coronary Stents Market research report has been segmented and sub-segmented into the following categories.

By Type

• Bare Metal Stents
• Drug-Eluting Stents
• Bioabsorbable Stents

By Mode of Delivery

• Balloon Expandable Stents
• Self-Expanding Stents

By Material

• Metallic stents
  • Cobalt chromium
  • Platinum chromium
  • Nickel-titanium
  • Stainless steel
• Other Stents

By End-User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC